Daymark Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Sell |
551
-225
| -29% | -$91.2K | 0.01% | 519 |
|
|
2025
Q1 | $386K | Buy |
776
+186
| +32% | +$92.6K | 0.02% | 370 |
|
|
2024
Q4 | $307K | Sell |
590
-119
| -17% | -$61.9K | 0.01% | 405 |
|
|
2024
Q3 | $439K | Buy |
709
+90
| +15% | +$55.7K | 0.02% | 355 |
|
|
2024
Q2 | $342K | Buy |
619
+122
| +25% | +$67.5K | 0.02% | 381 |
|
|
2024
Q1 | $289K | Buy |
497
+3
| +0.6% | +$1.74K | 0.02% | 349 |
|
|
2023
Q4 | $262K | Sell |
494
-119
| -19% | -$63.2K | 0.02% | 339 |
|
|
2023
Q3 | $310K | Sell |
613
-153
| -20% | -$77.4K | 0.02% | 299 |
|
|
2023
Q2 | $400K | Buy |
766
+101
| +15% | +$52.7K | 0.03% | 259 |
|
|
2023
Q1 | $383K | Buy |
+665
| New | +$383K | 0.05% | 207 |
|